
SCHOTT Pharma Investor Relations Material
Latest events

Q2 2025
SCHOTT Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SCHOTT Pharma AG & Co. KGaA
Access all reports
SCHOTT Pharma AG & Co. KGaA specializes in developing, producing, and selling advanced drug containment and delivery solutions for the injectable drugs market. Catering to the pharmaceutical and biotechnology industries globally, the company offers a comprehensive portfolio that includes polymer and glass syringes, ampoules, vials, and cartridges. Notable products in its range include the syriQ series of glass and polymer syringes designed for various applications such as vaccines, biologics, aesthetic treatments, infusion therapy, and deep-cold applications, as well as the cartriQ and adaptiQ lines for cartridges and vials, respectively. It is headquartered in Mainz, Germany, and its shares are listed on the Frankfurt Stock Exchange.
Key slides for SCHOTT Pharma AG & Co. KGaA


Q3 2024
SCHOTT Pharma AG & Co. KGaA


Q4 2024
SCHOTT Pharma AG & Co. KGaA
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
1SXP
Country
🇩🇪 Germany